Wird geladen...
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) was the first malignancy for which immunotherapy, in the form of allogeneic hematopoietic stem cell transplantation (allo-HSCT), was integrated into the standard of care. Allo-HSCT however is an imperfect therapy associated with significant morbidity and mortality while...
Gespeichert in:
| Veröffentlicht in: | Curr Drug Targets |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6321986/ https://ncbi.nlm.nih.gov/pubmed/25706110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389450116666150223120005 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|